Drug intelligence / Profile preview

Test Serum 897222 212

Development stage: Preclinical
Lead developer: Beijing Yuanben Information Consulting
Administration: Topical

Overview

Test Serum 897222 212 is an investigational topical product being evaluated for its efficacy in epidermal cell renewal. It is currently undergoing a single-center, double-blind, randomized, and controlled clinical study in Chinese female participants. The serum is applied repeatedly to the inner forearm over a period of 21 days to assess its effects on skin cell turnover and any potential adverse reactions.

Beyond the preview

Go deeper on Test Serum 897222 212.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Test Serum 897222 212.

Explore the full profile